Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324243
Status:
WITHDRAWN
Last Update Posted:
2019-01-10
First Post:
2017-10-18
Brief Title:
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With RelapsedRefractory FLT3-Mutated Acute Myeloid Leukemia
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| RelapsedRefractory FLT3-mutated AML |
Keywords: